Vir Biotechnology, Inc.

Historical 13F Holders

Symbol
VIR
CUSIP
92764N102
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 246 93.2 M $604 M
2024 Q4 223 88.8 M $652 M
2024 Q3 209 88.7 M $664 M
2024 Q2 227 91.4 M $814 M
2024 Q1 226 94.5 M $958 M
2023 Q4 218 91.1 M $917 M
2023 Q3 223 88.5 M $829 M
2023 Q2 245 90.8 M $2.23 B
2023 Q1 248 88.8 M $2.06 B
2022 Q4 237 91.6 M $2.32 B
2022 Q3 234 87.0 M $1.68 B
2022 Q2 222 86.2 M $2.20 B
2022 Q1 218 81.2 M $2.09 B
2021 Q4 233 78.3 M $3.26 B
2021 Q3 192 74.5 M $3.24 B
2021 Q2 179 76.9 M $3.64 B
2021 Q1 176 75.7 M $3.87 B
2020 Q4 163 79.0 M $2.12 B
2020 Q3 131 70.1 M $2.41 B
2020 Q2 123 53.5 M $2.19 B
2020 Q1 66 37.9 M $1.30 B
2019 Q4 40 36.6 M $460 M